Market Tracker

05/26 5:16pm ET

Endocyte Inc (NASDAQ:ECYT)

2.47
Delayed Data
As of May 26
 +0.02 / +0.82%
Today’s Change
1.98
Today|||52-Week Range
4.15
-3.14%
Year-to-Date

Today’s Trading

Previous close2.45
Today’s open2.45
Day’s range2.40 - 2.47
Volume170,481
Average volume (3 months)313,841
Market cap$104.9M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-6.12%
Earnings growth (this year)-15.06%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,537.67
Price/Book0.76

Competitors

 Today’s
change
Today’s
% change
ZFGNZafgen Inc-0.07-1.82%
RNNRexahn Pharmaceutica...+0.09+2.28%
ADMPAdamis Pharmaceutica...-0.10-2.63%
ORMPOramed Pharmaceutica...+0.03+0.37%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$70.0K
Annual profit (last year)-$43.9M
Net profit margin-62,696.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts